GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Homology Medicines Inc (LTS:0T6G) » Definitions » Forward Dividend Yield %

Homology Medicines (LTS:0T6G) Forward Dividend Yield % : 0.00% (As of Jun. 08, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Homology Medicines Forward Dividend Yield %?

As of today (2024-06-08), the Forward Annual Dividend Yield of Homology Medicines is 0.00%.

As of today (2024-06-08), the Trailing Annual Dividend Yield of Homology Medicines is 0.00%.

LTS:0T6G's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.68
* Ranked among companies with meaningful Forward Dividend Yield % only.

Homology Medicines's Dividends per Share for the three months ended in Dec. 2023 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Homology Medicines's Forward Dividend Yield %

For the Biotechnology subindustry, Homology Medicines's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Homology Medicines's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Homology Medicines's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Homology Medicines's Forward Dividend Yield % falls into.



Homology Medicines Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Homology Medicines  (LTS:0T6G) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Homology Medicines Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Homology Medicines's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Homology Medicines (LTS:0T6G) Business Description

Traded in Other Exchanges
Address
One Patriots Park, Bedford, MA, USA, 01730
Homology Medicines Inc is a United States-based genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a range of genetic disorders.

Homology Medicines (LTS:0T6G) Headlines

No Headlines